insights_auto
Why is EVT up 2,49%?
Dive Deeperchevron_right
EVT:ETR
Evotec SE
€2,63
arrow_upward
+2,49%(+0,064) 1D
19 Okt., 17:35:07 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVT...
Open
€2,54
High
€2,65
Low
€2,50
Mkt. cap
471,01Â m
Avg. vol.
1,17Â m
Volume
857,01Â k
52-wk high
€7,30
52-wk low
€2,41
EPS
-€1,11
Shares outstanding
177,91Â m
No. of employees
4Â k
Open
€2,54
High
€2,65
Low
€2,50
Mkt. cap
471,01Â m
Avg. vol.
1,17Â m
Volume
857,01Â k
52-wk high
€7,30
52-wk low
€2,41
EPS
-€1,11
Shares outstanding
177,91Â m
No. of employees
4Â k
News stories
From web sources and news partners
ad-hoc-news.de
·
8 uur gelede
Evotec stock: November 5, 2026 results date puts Evotec stock on the calendar
ad-hoc-news.de
·
16 uur gelede
RBC keeps EUR 10 target for Evotec stock. Price trades 1.56 percent below Xetra close
ad-hoc-news.de
·
17 uur gelede
Evotec stock at EUR 2.56 ahead of the Xetra open: drug discovery group slightly lower
ad-hoc-news.de
·
1 dag gelede
Evotec stock costs EUR 2.56 as Evotec reports preliminary results
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE